| Library / English Dictionary |
EPSTEIN-BARR VIRUS
| Pronunciation (US): |  | (GB): | |
I. (noun)
Sense 1
Meaning:
The herpes virus that causes infectious mononucleosis; associated with specific cancers in Africa and China
Synonyms:
Classified under:
Hypernyms ("Epstein-Barr virus" is a kind of...):
herpes; herpes virus (any of the animal viruses that cause painful blisters on the skin)
Context examples:
A measurement of the Epstein-Barr virus viral load in a biological specimen.
(Epstein-Barr Virus Viral Load Measurement, NCI Thesaurus/CDISC)
Infectious mononucleosis, or "mono", is an infection usually caused by the Epstein-Barr virus.
(Infectious Mononucleosis, NIH)
This disorder is often Epstein-Barr virus positive, and morphologically it may resemble large B-cell non-Hodgkin's lymphoma, Hodgkin's lymphoma, or a polymorphous post-transplant lymphoproliferative disorder.
(Methotrexate-Associated Lymphoproliferative Disorder, NCI Thesaurus/WHO)
A treatment for Epstein-Barr virus infection or overgrowth of white blood cells (lymphocytes) after an organ or bone marrow transplant.
(Peripheral blood lymphocyte therapy, NCI Dictionary)
It is often associated with Epstein-Barr virus infection, hepatitis B infection or cytomegalovirus infection.
(Acrodermatitis, NCI Thesaurus)
A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity.
(Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine, NCI Thesaurus)
An epithelial hyperplasia of the oral cavity mucosa associated with Epstein-Barr virus and found almost exclusively in persons with HIV infection.
(Oral Cavity Hairy Leukoplakia, NCI Thesaurus)
Autologous dendritic cells (DCs) transduced with the replication-deficient adenoviral vector Ad5F53 encoding the Epstein-Barr virus (EBV) transmembrane latent membrane proteins 1 and 2 (LMP1/LMP2) with potential immunostimulatory activity.
(Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells, NCI Thesaurus)
The treatment targets the Epstein-Barr virus in the brain that Australian researchers believe plays a role in the development of Multiple Sclerosis, or MS, a disease of the central nervous system.
(Multiple Sclerosis Treatment Developed in Australia Shows Promise, VOA)
Allogeneic tri-viral specific, adenovirus, cytomegalovirus and Epstein-Barr virus (Adv, CMV and EBV or ACE), cytotoxic T-lymphocytes (CTLs) with potential antiviral activity.
(Adenovirus/Cytomegalovirus/Epstein-Barr Virus-specific Allogeneic Cytotoxic T Lymphocytes, NCI Thesaurus)
